Related Experiment Video

Updated: Aug 18, 2025

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.3K

Mixed outcomes following a third SARS-CoV-2 vaccine dose in previously unresponsive people with HIV

Nolan Hassold1, Ségolène Brichler2, Yamina Gater2

  • 1Department of Infectious and Tropical Diseases, Hôpital Avicenne AP-HP, 125 rue de Stalingrad, 93000, Bobigny, France.

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|December 8, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Anti-SARS-COV-2 antibodiesCD4+ T-cellCOVID-19HIV-1SARS-COV-2 vaccine

More Related Videos

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.4K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
31.4K
Vaccinations01:51

Vaccinations

Overview
45.1K